Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors

Completed · Not applicable

Conditions studied: Endometrial Cancer, Obesity

In brief

This pilot clinical trial studies protein-sparing modified fast (PSMF) intervention for weight loss in obese endometrial cancer survivors. The PSMF is a diet that is very low in carbohydrates and calories, designed to induce fast, safe weight loss. The diet consists of only lean meats (beef, pork, poultry, and seafood) in amounts adequate to meet protein requirements based on the individual's body weight. The PSMF may help endometrial cancer survivors achieve significant weight loss, reduce the risk of chronic disease, and improve quality of life.

Key facts

Study ID

NCT02135562

Run by

Case Comprehensive Cancer Center

People needed

11

Starts

2014-08-08

Expected to finish

2017-04-19

Last updated by the study team

2017-09-20

Who can join

Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Previous diagnosis of endometrial cancer, successfully treated through surgery
• Body mass index (BMI) > 30 kg/m\^2
• > 8 weeks removed from surgery to treat endometrial cancer

You may not qualify if…

• No previous diagnosis of endometrial cancer
• BMI < 30 kg/m\^2
• Any history of cardiovascular, kidney, or liver disease
• Using medication to treat diabetes
• History of cardiac arrhythmias
• Inability to comply with follow up regimen
• Inability to read or speak English
• Abstention from meat and other animal products

Where it is running

• Cleveland Medical Center, University Hospitals, Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
• MetroHealth Medical Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.